These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26845235)

  • 1. Fragment Screening of Soluble Epoxide Hydrolase for Lead Generation-Structure-Based Hit Evaluation and Chemistry Exploration.
    Xue Y; Olsson T; Johansson CA; Öster L; Beisel HG; Rohman M; Karis D; Bäckström S
    ChemMedChem; 2016 Mar; 11(5):497-508. PubMed ID: 26845235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Potent Soluble Epoxide Hydrolase (sEH) Inhibitors by Pharmacophore-Based Virtual Screening.
    Waltenberger B; Garscha U; Temml V; Liers J; Werz O; Schuster D; Stuppner H
    J Chem Inf Model; 2016 Apr; 56(4):747-62. PubMed ID: 26882208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insights into binding of inhibitors to soluble epoxide hydrolase gained by fragment screening and X-ray crystallography.
    Amano Y; Yamaguchi T; Tanabe E
    Bioorg Med Chem; 2014 Apr; 22(8):2427-34. PubMed ID: 24656800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of N-ethylmethylamine as a novel scaffold for inhibitors of soluble epoxide hydrolase by crystallographic fragment screening.
    Amano Y; Tanabe E; Yamaguchi T
    Bioorg Med Chem; 2015 May; 23(10):2310-7. PubMed ID: 25862210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of potent inhibitors of soluble epoxide hydrolase by combinatorial library design and structure-based virtual screening.
    Xing L; McDonald JJ; Kolodziej SA; Kurumbail RG; Williams JM; Warren CJ; O'Neal JM; Skepner JE; Roberds SL
    J Med Chem; 2011 Mar; 54(5):1211-22. PubMed ID: 21302953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial Expression and HTS Assessment of Soluble Epoxide Hydrolase Phosphatase.
    Klingler FM; Wolf M; Wittmann S; Gribbon P; Proschak E
    J Biomol Screen; 2016 Aug; 21(7):689-94. PubMed ID: 27009944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the binding mode of 1, 3, 4-oxadiazole derivatives as amide-based inhibitors for soluble epoxide hydrolase (sEH) by molecular docking and MM-GBSA.
    Karami L; Saboury AA; Rezaee E; Tabatabai SA
    Eur Biophys J; 2017 Jul; 46(5):445-459. PubMed ID: 27928588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional rational approach to the discovery of potent substituted cyclopropyl urea soluble epoxide hydrolase inhibitors.
    Takai K; Chiyo N; Nakajima T; Nariai T; Ishikawa C; Nakatani S; Ikeno A; Yamamoto S; Sone T
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1705-1708. PubMed ID: 25800114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A practical use of ligand efficiency indices out of the fragment-based approach: ligand efficiency-guided lead identification of soluble epoxide hydrolase inhibitors.
    Tanaka D; Tsuda Y; Shiyama T; Nishimura T; Chiyo N; Tominaga Y; Sawada N; Mimoto T; Kusunose N
    J Med Chem; 2011 Feb; 54(3):851-7. PubMed ID: 21192659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity relationship of piperidine-derived non-urea soluble epoxide hydrolase inhibitors.
    Pecic S; Pakhomova S; Newcomer ME; Morisseau C; Hammock BD; Zhu Z; Rinderspacher A; Deng SX
    Bioorg Med Chem Lett; 2013 Jan; 23(2):417-21. PubMed ID: 23237835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of soluble epoxide hydrolase (sEH) activity.
    Morisseau C; Hammock BD
    Curr Protoc Toxicol; 2007; Chapter 4():Unit 4.23. PubMed ID: 23045145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human soluble epoxide hydrolase: structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids.
    Gomez GA; Morisseau C; Hammock BD; Christianson DW
    Protein Sci; 2006 Jan; 15(1):58-64. PubMed ID: 16322563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of structure-derived pharmacophore of soluble epoxide hydrolase inhibitors by virtual screening.
    Moser D; Achenbach J; Klingler FM; Estel la B; Hahn S; Proschak E
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6762-5. PubMed ID: 23017883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatase activity of soluble epoxide hydrolase.
    Kramer J; Proschak E
    Prostaglandins Other Lipid Mediat; 2017 Nov; 133():88-92. PubMed ID: 28729091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility.
    Kim IH; Heirtzler FR; Morisseau C; Nishi K; Tsai HJ; Hammock BD
    J Med Chem; 2005 May; 48(10):3621-9. PubMed ID: 15887969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble epoxide hydrolase inhibitors with carboranes as non-natural 3-D pharmacophores.
    Scholz MS; Wingen LM; Brunst S; Wittmann SK; Cardoso ILA; Weizel L; Proschak E
    Eur J Med Chem; 2020 Jan; 185():111766. PubMed ID: 31677445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent Vasodilators.
    Tripathi N; Paliwal S; Sharma S; Verma K; Gururani R; Tiwari A; Verma A; Chauhan M; Singh A; Kumar D; Pant A
    Sci Rep; 2018 Oct; 8(1):14604. PubMed ID: 30279487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into the binding modes and inhibition mechanisms of adamantyl-based 1,3-disubstituted urea inhibitors in the active site of the human soluble epoxide hydrolase.
    Chen H; Zhang Y; Ye C; Feng TT; Han JG
    J Biomol Struct Dyn; 2014; 32(8):1231-47. PubMed ID: 23815795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-urea functionality as the primary pharmacophore in soluble epoxide hydrolase inhibitors.
    Anandan SK; Do ZN; Webb HK; Patel DV; Gless RD
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1066-70. PubMed ID: 19168352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble epoxide hydrolase inhibitory components from Rheum undulatum and in silico approach.
    Jo AR; Kim JH; Yan XT; Yang SY; Kim YH
    J Enzyme Inhib Med Chem; 2016; 31(sup2):70-78. PubMed ID: 27555350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.